NCT00488098View on ClinicalTrials.gov

GSK372475 Bioequivalence Study

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 31, 2007

Conditions
Healthy SubjectsDepressive Disorder
Interventions
DRUG

GSK372475

Trial Locations (1)

M1L 4S4

GSK Investigational Site, Toronto

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY